Patents for C12R 1 - Micro-organisms (92,025) |
---|
11/19/1992 | EP0513565A1 Monoclonal antibodies against the plasmin-antiplasmin complex, process for their preparation and their use |
11/19/1992 | EP0513371A1 Human parainfluenza virus type 4a fusion protein and gene which codes for the same |
11/19/1992 | EP0513336A1 New variants derived from interferons of type i, production process thereof and their applications |
11/19/1992 | EP0513316A1 Analytical tracers for cancer, particularly malignant breast cancer. |
11/19/1992 | EP0513201A1 Leukocyte-derived growth factor |
11/19/1992 | EP0513090A1 Hepatitis a vaccines |
11/19/1992 | EP0513073A1 PROCESS FOR ENZYMATICAL CLEAVAGE OF RECOMBINANT PROTEINS BY MEANS OF IgA PROTEASES. |
11/19/1992 | EP0477290A4 Methods, compositions and devices for growing cells |
11/18/1992 | CN1066292A Compounds, named "leustroducsins", their preparation and their therapeutic uses |
11/18/1992 | CN1066285A Continuous process for biocatalytic desulfurization of sulfur-bearing heterocyclic molecules |
11/18/1992 | CN1066272A Process for preparation of anti-thrombin polypeptides |
11/18/1992 | CA2068813A1 Hybrid monoclonal antibodies and compositions containing them |
11/18/1992 | CA2068372A1 Human neurokinin-1 receptor short form |
11/17/1992 | US5164507 Fungicide |
11/17/1992 | US5164489 Protein growth factor useful in diagnosis and treatment of lung cancer |
11/17/1992 | US5164482 Recombinant aprotinin variants genetically engineered process for the microbial preparation of homogeneously processed aprotinin variants and the therapeutic use thereof |
11/17/1992 | US5164389 Anthelmintic bioconversion products |
11/17/1992 | US5164369 Asparagine, leucine, arginine, cysteine |
11/17/1992 | US5164366 Diabetes |
11/17/1992 | US5164314 Microbiologically-prepared diacetyl reductase |
11/17/1992 | US5164309 Process for the microbiological preparation of 1,3-propane-diol from glycerol by citrobacter |
11/17/1992 | US5164308 Preparation of labelled triglyceride oils by cultivation of microorganisms |
11/17/1992 | CA2068811A1 Protein from lactic acid bacteria |
11/17/1992 | CA2068764A1 Monoclonal antibodies against the plasmin-antiplasmin complex, a method for the preparation thereof and the use thereof |
11/17/1992 | CA1310286C Isolation of a gene encoding human thyrotropin beta subunit |
11/14/1992 | WO1992020805A1 Recombinant dna coding for signal peptide, selective interacting polypeptide and membrane anchoring sequence |
11/12/1992 | WO1992020060A1 Electrophoretic display panel with tapered grid insulators and associated methods |
11/12/1992 | WO1992019973A1 Novel antibodies, and methods for their use |
11/12/1992 | WO1992019759A1 Reconstituted human antibody against human interleukin 6 receptor |
11/12/1992 | WO1992019753A1 Genetic control of acetylation and pyruvylation of xanthan based polysaccharide polymers |
11/12/1992 | WO1992019750A1 Hybrid transposon with a pt-operon, plasmids and bacterial strains therefor |
11/12/1992 | WO1992019741A1 Hbv virus surface proteins with reduced host carbohydrate |
11/12/1992 | WO1992019740A1 Multiple hepatitis b virus surface proteins which form particles |
11/12/1992 | WO1992019737A1 Process for producing a monocyte chemotactic factor polypeptide and a strain for the production thereof |
11/12/1992 | WO1992019736A1 Growth hormone antagonists |
11/12/1992 | WO1992019735A1 GLYCAM-1 (Sgp 50), A SELECTIN LIGAND |
11/12/1992 | WO1992019734A1 Binding domains in notch and delta proteins |
11/12/1992 | WO1992019729A1 Stabilized enzymes and detergent compositions |
11/12/1992 | WO1992019728A1 Rhamnogalacturonase, corresponding dna sequence, rhamnogalacturonase containing enzyme preparation and use of the enzyme preparation |
11/12/1992 | WO1992019726A1 Stabilized enzymes |
11/12/1992 | WO1992019721A1 Gene expression in bacilli |
11/12/1992 | WO1992019717A1 A high-affinity human glutamate/aspartate uptake system |
11/12/1992 | WO1992019650A1 Monoclonal antibodies specific for human thymidylate synthase |
11/12/1992 | WO1992019106A1 Novel bacillus thuringiensis isolates for controlling acarides |
11/12/1992 | DE4115340A1 Mikrobiologisch hergestellte trimethylamin-dehydrogenase, verfahren zu ihrer gewinnung und ihre verwendung Microbiologically produced trimethylamine dehydrogenase, process for their manufacture and their use |
11/12/1992 | CA2109218A1 Rhamnogalacturonase, corresponding dna sequence, rhamnogalacturonase containing enzyme preparation and use of the enzyme preparation |
11/12/1992 | CA2109086A1 Monoclonal antibodies specific for human thymidylate synthase |
11/12/1992 | CA2108451A1 Novel antibodies, and methods for their use |
11/12/1992 | CA2108248A1 Novel bacillus thuringiensis isolates for controlling acarides |
11/12/1992 | CA2108029A1 Glycam-1(sgp 50), a selectin ligand |
11/12/1992 | CA2102508A1 Electrophoretic display panel with tapered grid insulators and associated methods |
11/11/1992 | EP0512905A2 Heterobifunctional antibodies possessing both catalytic and specific antigen binding properties and methods using them |
11/11/1992 | EP0512857A2 Composition comprising bacterial culture residue and decapsulated bacterial cells and its use |
11/11/1992 | EP0512848A2 Enzymatic resolution of alpha-tertiary carboxylic acid esters |
11/11/1992 | EP0512830A2 Yeast mutants and identification of immunosuppressant agents |
11/11/1992 | EP0512824A1 Anti-bacterial compound |
11/11/1992 | EP0512733A2 Modified complement system regulator |
11/11/1992 | EP0512522A1 Novel antibiotic compounds and their production |
11/11/1992 | EP0512074A1 Molecules with antibody combining sites that catalyse hydrolysis reactions |
11/11/1992 | EP0512066A1 Co-independent growth medium for maintenance and propagation of cells. |
11/11/1992 | EP0512023A1 Medicaments and methods for treating aids and arc employing anti-carbohydrate antibodies and carbohydrate antigens |
11/11/1992 | EP0511978A1 Method of purifying recombinant polypeptides. |
11/11/1992 | EP0511959A1 Method for recovering solubilized proteins |
11/11/1992 | EP0330695B1 Process for preparation of organic chemicals |
11/11/1992 | EP0202300B1 Cdna clones coding for polypeptides exhibiting human granulocyte macrophage and eosinophil cellular growth factor activity |
11/10/1992 | US5162498 Synthetic yeast leader peptides |
11/10/1992 | US5162368 Butalactin and its use as pharmaceutical |
11/10/1992 | US5162330 Dynemicin c antibiotic, its triacetyl derivative and pharmaceutical composition containing same |
11/10/1992 | US5162228 Gylceraldehyde-3-phosphate dehydrogenase gene and promoter |
11/10/1992 | US5162227 Recombinant DNA vectors capable of expressing apoaequorin in E. coli |
11/10/1992 | US5162226 Therapeutic compositions against streptococcal infections, transformed hosts, methods of immunization and genetically engineered products |
11/10/1992 | US5162221 Fructose-1,6-bisphosphate aldolase, a process for the preparation thereof and its use |
11/10/1992 | US5162220 Kex2 endoprotease without a c-terminal hydrophobic region |
11/10/1992 | US5162212 Transaminase from E. coli DH-1 (ATCC 33849) |
11/10/1992 | US5162208 Saccharomyces cerevisiae strain productive of a heterologous protein and process for preparing the said heterologous protein by fermentation of the said strain |
11/10/1992 | US5162207 Sucrose inducible expression vectors for bacillus sp. |
11/10/1992 | US5162112 Influenza vaccine |
11/10/1992 | CA1309960C Micro-organisms and plasmids for the constitutive formation of creatinamidinohydrolase and processes for the production thereof |
11/10/1992 | CA1309959C Parathryoid-specific radioimaging techniques |
11/09/1992 | CA2068038A1 Enzymatic resolution of .alpha.-tertiary carboxylic acid esters |
11/08/1992 | CA2068062A1 Yeast mutants |
11/07/1992 | WO1992019255A1 Gene manipulation and expression using genomic elements |
11/07/1992 | CA2102628A1 Gene manipulation and expression using genomic elements |
11/04/1992 | EP0511933A2 Dictyoglomus microorganisms and their xylanolytic enzymes |
11/04/1992 | EP0511912A1 Yeast promoter and its use |
11/04/1992 | EP0511881A1 Novel anthelmintic milbemycin analogs of novel microorganisms |
11/04/1992 | EP0511855A1 HBsAg escape mutant vaccine |
11/04/1992 | EP0511854A1 Multiple hepatitis B virus surface proteins which form particles |
11/04/1992 | EP0511816A2 Neurotrophic peptide derivative |
11/04/1992 | EP0511784A1 Low-ash xanthan gum |
11/04/1992 | EP0511759A1 Biotoxicity test for chemicals |
11/04/1992 | EP0511747A1 Hybrid polypeptide containing an avidin binding polypeptide |
11/04/1992 | EP0511690A2 Family of xanthan-based polysaccharide polymers including non-acetylated and/or non-pyruvylated gum |
11/04/1992 | EP0511516A2 Schizosaccharomyces specific polypeptide |
11/04/1992 | EP0511311A1 Novel retroviral vectors |
11/04/1992 | EP0511300A1 Monoclonal antibody specific for non-immunodominant epitope of hiv proteins |
11/04/1992 | EP0511285A1 Vector with multiple target response elements affecting gene expression |
11/04/1992 | EP0511263A1 A platelet cell adhesion molecule and variants thereof |
11/04/1992 | EP0511238A1 A process for the simultaneous production of xylitol and ethanol. |
11/04/1992 | EP0511221A1 Process for enriching or cleaning hirudin. |